Month: May 2024

Protocol for Oversight of BA/BE Study Sites and Monitoring Activities Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for clinical monitoring and site management activities in Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all personnel involved in the oversight and monitoring…

Read More “SOP for Clinical Monitoring and Site Management” »

Procedure for Administering Investigational Products in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the safe and accurate administration of study drugs or investigational products in Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all personnel involved in the…

Read More “SOP for Drug Administration” »

Protocol for Management of Investigational Products in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the handling, storage, and accountability of study drugs or investigational products used in Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all personnel involved…

Read More “SOP for Study Drug Handling and Storage” »

Procedure for Randomization and Masking in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the randomization and blinding processes in Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all personnel involved in the design, conduct, and analysis of BA…

Read More “SOP for Randomization and Blinding” »